UBS Group
OGN icon

UBS Group’s Organon & Co OGN Stock Holding History

UBS Group’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.8M Buy
4,856,529
+1,384,950
+40% +$16.6M 0.01% 1486
2026
Q1 		$20.8M Sell
3,471,579
-823,423
-19% -$6.2M ﹤0.01% 2534
2025
Q4 		$30.8M Buy
4,295,002
+1,527,492
+55% +$12.1M 0.01% 2148
2025
Q3 		$29.6M Sell
2,767,510
-3,192,282
-54% -$31.3M ﹤0.01% 2148
2025
Q2 		$57.7M Buy
5,959,792
+4,185,464
+236% +$43.2M 0.01% 1384
2025
Q1 		$26.4M Sell
1,774,328
-1,518,225
-46% -$23.3M ﹤0.01% 2086
2024
Q4 		$49.1M Buy
3,292,553
+2,876,254
+691% +$46.9M 0.01% 1485
2024
Q3 		$7.96M Sell
416,299
-1,737
-0.4% -$36K ﹤0.01% 2589
2024
Q2 		$8.65M Sell
418,036
-212,415
-34% -$4.22M ﹤0.01% 2339
2024
Q1 		$11.9M Buy
630,451
+87,120
+16% +$1.5M ﹤0.01% 2134
2023
Q4 		$7.83M Sell
543,331
-114,581
-17% -$1.56M ﹤0.01% 2317
2023
Q3 		$11.4M Buy
657,912
+308,470
+88% +$6.43M ﹤0.01% 1887
2023
Q2 		$7.27M Sell
349,442
-10,372
-3% -$225K ﹤0.01% 2234
2023
Q1 		$8.46M Sell
359,814
-334,003
-48% -$8.97M ﹤0.01% 2020
2022
Q4 		$19.4M Buy
693,817
+101,023
+17% +$2.58M 0.01% 1441
2022
Q3 		$13.9M Buy
592,794
+147,065
+33% +$4.44M 0.01% 1523
2022
Q2 		$15M Buy
445,729
+16,505
+4% +$578K 0.01% 1523
2022
Q1 		$15M Sell
429,224
-79,572
-16% -$2.72M 0.01% 1649
2021
Q4 		$15.5M Buy
508,796
+14,687
+3% +$478K ﹤0.01% 1764
2021
Q3 		$16.2M Sell
494,109
-308,873
-38% -$9.88M 0.01% 1662
2021
Q2 		$24.3M Buy
+802,982
New +$26.4M 0.01% 1344

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

UBS Group's OGN Position: Q2 2026 in Review

UBS Group increased its Organon & Co (OGN) stake by 40% in Q2 2026, buying an estimated $16.6M and bringing the position to 4,856,529 shares worth $65.8M. The position accounts for 0.01% of the portfolio, ranked #1486.

UBS Group first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • UBS Group held 4,856,529 shares of Organon & Co worth $65.8M as of Q2 2026.
  • UBS Group bought 1,384,950 Organon & Co shares in Q2 2026, an estimated $16.6M.
  • Organon & Co made up 0.01% of UBS Group's portfolio in Q2 2026, its #1486 holding.
  • UBS Group first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.